CymaBay Therapeutics (CBAY) – Analyst EPS View
-
CymaBay Therapeutic (CBAY) PT Raised to $19 at SunTrust Robinson Humphrey; 'Remain Bullish... Would be Strong Buyers'
-
CymaBay Therapeutic (CBAY) PT Raised to $12 at H.C. Wainwright; 'Seladelpar's Phase 2 PBC Results More Robust Than Ocaliva'
-
-
Back to CBAY Stock Lookup